Please login to the form below
Scotland
This page shows the latest Scotland news and features for those working in and with pharma, biotech and healthcare.
Valneva to compare its COVID-19 vaccine candidate to AstraZeneca’s jab
The UK has been at the forefront of cutting-edge innovation throughout this pandemic, with Valneva’s vaccine set to be made in Scotland, if approved. ... At the time, the UK government confirmed that Valneva had already started manufacturing doses of
Latest news
-
Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
Another real-world study, conducted in Scotland by the University of Edinburgh’s Usher Institute, found that by the fourth week after receiving the first dose, the Pfizer/BioNTech and
-
UK approval for Seagen’s oral HER2 inhibitor Tukysa
The EC approval for Tukysa is valid in Northern Ireland, while the MHRA authorisation covers England, Scotland and Wales.
-
First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
Another study, conducted in Scotland by the University of Edinburgh’s Usher Institute, found that by the fourth week after receiving the first dose, the Pfizer/BioNTech and AZ/Oxford vaccines ... director at Public Health Scotland.
-
UK orders 40 million additional doses of Valneva’s COVID-19 vaccine
A report in The Mail on Sunday said that Valneva is preparing to begin manufacturing doses of the vaccine for commercial use at its site in Livingston, Scotland. ... The UK government has invested a ‘multi-million sum’ in a facility based in
-
The UK reasserts that the AZ vaccine is ‘effective across all age groups’
However, Johnson said that he “doesn’t agree” with this assessment of the vaccine, adding during a visit to Scotland that “[British] authorities have made it very clear that they think
More from news
Approximately 7 fully matching, plus 239 partially matching documents found.
Latest Intelligence
-
Creativity in storytelling: why pharma must invest more in creativity
Guy Vickerstaff, Chair of IPA Scotland, said: “For all the data, for all the latest tech, for all the influencers and all the noise, it’s all too easy to lose
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
Different from the 2014 PPRS is the requirement for companies to offer the same deal – whether agreed in England, Scotland, Wales or Northern Ireland – across all nations.
-
The Orkambi row explained
May 2016: Orkambi and Kalydeco rejected in Scotland. June 2016: NICE gives final rejection of Orkambi in England – the Cystic Fibrosis Trust suggests a solution using the UK CF Registry to
-
The Orkambi blame game
Leiden added: “It could be the same price as Scotland. That’s the quickest way.”. ... Deciphering the feasibility of this hope was difficult for the MPs, as Scotland’s deal with Vertex remains confidential.
-
#OrkambiNow?
A market access deal with Scotland’s government has provided new impetus to the talks in England, with the hope that both sides can climb down and reach agreement soon.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest appointments
-
ClinTec International adds to senior leadership team
Prior to working for inVentiv Health, Dr Reekie served as chief operating officer at PharmaNet prior to its acquisition by inVentiv, commercial director at Stratified Medicine Scotland-Innovation Centre and head
-
ABPI Scotland appoints Sandra Auld as director
She will spearhead the ABPI Scotland team, working closely with the Scottish Government and NHS Scotland. . ... Auld added: “I am absolutely delighted to become the Director of ABPI Scotland.
-
Former RBS head takes the reins as GSK chair
Sir Philip, formerly the chair of the Royal Bank of Scotland, replaces Sir Christopher Gent, who announced he would step down from the position last year.
-
EFPIA looks to ABPI for comms director
Powrie-Smith is currently director of the ABPI's operations in Scotland and also heads the trade body's Trust and Reputation network.
-
Sir Philip Hampton set to be new GSK chair
RBS chairman to replace Sir Christopher Gent. GlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to
More from appointments
Approximately 2 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
The heavy toll of COVID-19 on cancer patients
This drop is due to a number of reasons. Scotland, Wales, and Northern Ireland all paused their national screening programs for cancer during the lockdown.
-
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
I wasn’t long returned from my year out as an Au-Pair in Italy, and given that I hadn’t even packed a skirt when I left Scotland for my
-
Homeworking: The positives and tips from the experience of the Valid Insight Team
At Valid Insight, we have had a homeworking model since our inception; a model designed to enable us to attract and recruit experienced professionals from many geographies, without the need to uproot family, travel regularly or experience long
-
Pricing and Market Access Simulator
Germany, Italy, Netherlands, Poland, Portugal, Scotland, Spain, Sweden, and US.
-
Spotlight interview: 15 minutes on PR in pharma
Going back to my point about public relations being so diverse these days, our work is so varied whether we are supporting a reimbursement decision in Scotland to launching a global
More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive Salary
-
Associate Account Director
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Account Manager
-
Competitive Salary
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Senior Medical Writer
-
Competitive Salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Roche’s Ocrevus shows significant benefit in early-stage MS patients
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Leaders in Pharma: Samir Vattompadam
- Building Better Access to Pediatric Care Through Telehealth
- Building trust through sustainability communications
- Healthware Group acquires London-headquartered consultancy SWM
- Lucid Group promotes Clare Reynolds to Director of Business Development and Commercial Integration
- Are you ready for the digital health revolution?
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- Are you ready for the digital health revolution?
- In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
- #DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
- Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
- Empowering patients empowers results
- Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Quick links
Infographics
